Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

May 6, 2020

284_dirs_2020-05-06_363f672e-d134-4124-a71d-240db347175d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-04

Reporting Person: Nally Michael (EVP, Chief Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-04 Common Stock M 1298 $77.67 Acquired 10273.935 Direct
2020-05-04 Common Stock F 565 $77.67 Disposed 9708.935 Direct
2020-05-05 Common Stock M 2345 $76.86 Acquired 12053.935 Direct
2020-05-05 Common Stock F 1020 $76.86 Disposed 11033.935 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-04 Restricted Stock Unit $ M 1298 Disposed 2021-05-04 Common Stock (1298) Direct
2020-05-05 Restricted Stock Unit $ M 2345 Disposed 2020-05-05 Common Stock (2345) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 1720.848 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through April 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.